9.020000 USD
0.53
5.55%
Last update Dec 12, 3:59 PM EST
Market closed
Day range
9.020000
9.67990
Previous close
9.55000
Open
9.60000
Access this stock data via API
Subscribe
Intellia Therapeutics Inc.
9.02
0.53
5.55%

Financials

Income statement

Fiscal date Sep 2025 Jun 2025 Mar 2025 Dec 2024
Total reported revenue 13.8M 14.2M 16.6M 12.9M
Cost of revenue
Gross profit
Operating expense
Research & development 94.7M 97.0M 108.4M 116.9M
Selling general and admin 30.5M 27.2M 29.0M 32.4M
Other operating expenses
Operating income -111.5M -110.0M -120.8M -136.4M
Non operating interest income
Income 6.7M 7.4M 8.6M 10.6M
Expense
Other income expense 3.4M 1.3M -2.1M -3.1M
Pretax income -101.3M -101.3M -114.3M -128.9M
Tax provision
Net income -101.3M -101.3M -114.3M -128.9M
Basic EPS -0.9 -1.0 -1.1 -1.3
Diluted EPS -0.9 -1.0 -1.1 -1.3
Basic average shares 110.2M 103.7M 103.5M 101.9M
Diluted average shares 110.2M 103.7M 103.5M 101.9M
EBITDA -110.0M -108.9M -116.2M -130.8M
Net income from continuing op. -101.3M -101.3M -114.3M -128.9M
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Market closed

Exchange is currently closed
Pre-market opens in 3 hours 29 minutes

00:30
00:00
09:30
16:00
23:59

Trading Hours (Monday - Friday):

Pre-market
04:00 - 09:30
Main market
09:30 - 16:00
Post-market
16:00 - 20:00
All times are displayed in the America/New_York timezone (EST, UTC-05:00).